Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Oragenics Inc (OGEN)

0.3941   0.008 (2.1%) 11-27 01:18
Open: 0.39 Pre. Close: 0.386
High: 0.415 Low: 0.39
Volume: 4,079,994 Market Cap: 30M
Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. The company is headquartered in Tampa, Florida and currently employs 12 full-time employees. The firm is focused on offering antibiotics against infectious disease and on developing treatments for oral mucositis. The company is engaged in developing its antibiotic product candidate, MU1140, as well as other homolog antibiotic product candidates; researching AG013 in connection with the treatment of Oral Mucositis; commercializing its ProBiora3 probiotic products, and has other product candidates for out licensing or partnering. MU1140 is an antibiotic that is produced by the parent of the SMaRT strain. ProBiora3 is a blend of three naturally occurring strains of beneficial bacteria, including Streptococcus oralis KJ3, Streptococcus uberis KJ2 and Streptococcus rattus JH145. LPT3-04 is a compound, which is consumed in the human diet in small amounts and results in dose-dependent weight loss in experimental animal models.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.41 - 0.412 0.412 - 0.414
Low: 0.386 - 0.387 0.387 - 0.389
Close: 0.387 - 0.39 0.39 - 0.393

Technical analysis

as of: 2020-11-25 4:42:17 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.58     One year: 0.67
Support: Support1: 0.38    Support2: 0.32
Resistance: Resistance1: 0.50    Resistance2: 0.57
Pivot: 0.46
Moving Average: MA(5): 0.42     MA(20): 0.47
MA(100): 0.74     MA(250): 0.63
MACD: MACD(12,26): -0.04     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 6.31     %D(3): 14.76
RSI: RSI(14): 34.97
52-week: High: 2.09  Low: 0.36  Change(%): -36.4
Average Vol(K): 3-Month: 260120  10-Days: 521637

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
OGEN has closed above bottom band by 12.7%. Bollinger Bands are 49.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to OGEN's normal range. The bands have been in this narrow range for 35 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 24 Nov 2020
Oragenics Announces Closing of $6.0 Million Underwritten Public Offering - Business Wire

Mon, 23 Nov 2020
Oragenics' $5.25M stock sale to fund Covid-19 vaccine development - Tampa Bay Business Journal

Mon, 23 Nov 2020
Oragenics Inc. (OGEN) and the Battle of Fundamentals vs. Technicals - The News Heater

Mon, 23 Nov 2020
Investing in Oragenics, Inc. (NYSE:OGEN) Stock. OGEN Performance & Trends - Marketing Sentinel

Fri, 20 Nov 2020
Oragenics Inc (OGEN) Stock: What Does the Chart Say? - InvestorsObserver

Fri, 20 Nov 2020
At $0.47 Price, Oragenics, Inc. (OGEN) Sits And Waits For Direction - Stocks Register

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 61
Shares Float (M) 42
% Held by Insiders 4.96
% Held by Institutions 19.36
Shares Short (K) 2,310
Shares Short P. Month (K) 1,600

Stock Financials

EPS -0.523
EPS Est This Year -0.180
EPS Est Next Year -0.230
Book Value (p.s.) 0.030
Profit Margin
Operating Margin
Return on Assets (ttm) -83.5
Return on Equity (ttm) -150.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.412
Qtrly Earnings Growth
Operating Cash Flow (M) -16
Levered Free Cash Flow (M) -7

Stock Valuations

PE Ratio -0.75
PEG Ratio
Price to Book value 13.14
Price to Sales
Price to Cash Flow -1.50

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.